NDAINJECTIONINJECTABLEPriority Review
Approved
Aug 1952
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Data completeness
4/8 — Partial
Priority Review
ANECTINE (succinylcholine chloride) by Novartis is blocker. Approved for mechanical ventilation. First approved in 1952.
Drug data last refreshed 20h ago
Mechanism of Action
blocker. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the…
Indications (1)
Worked on ANECTINE at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.